Cargando…

Manufacture and evaluation of a HER2-positive breast cancer immunotoxin 4D5Fv-PE25

BACKGROUND: Human epidermal growth factor receptor 2 (HER2) positive breast cancer is an aggressive subtype, accounting for around 20% of all breast cancers. The development of HER2-targeted therapy has substantially improved patient outcomes. Nevertheless, the increasing rate of side effects and re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Yanjie, Wu, Zhengli, Pang, Zheng, Zhang, Lin, Song, Dandan, Liu, Fang, Li, Yanhong, Lin, Tongjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190103/ https://www.ncbi.nlm.nih.gov/pubmed/37198642 http://dx.doi.org/10.1186/s12934-023-02115-0

Ejemplares similares

Recombinant Immunotoxin 4D5scFv-PE40 for Targeted Therapy of HER2-Positive Tumors
por: Sokolova, E. A., et al.
Publicado: (2015)

Soluble Cytoplasmic Expression and Purification of Immunotoxin HER2(scFv)-PE24B as a Maltose Binding Protein Fusion
por: Park, Sangsu, et al.
Publicado: (2021)

Expression and Evaluation of HuscFv Antibody -PE40 Immunotoxin for Target Therapy of EGFR-Overexpressing Cancers
por: Falahatgar, Dianoush, et al.
Publicado: (2018)

HER2-specific recombinant immunotoxin 4D5scFv-PE40 passes through retrograde trafficking route and forces cells to enter apoptosis
por: Sokolova, Evgeniya, et al.
Publicado: (2017)

Spheroids of HER2-Positive Breast Adenocarcinoma for Studying Anticancer Immunotoxins In Vitro
por: Balalaeva, I. V., et al.
Publicado: (2017)

Towards Engineering Novel PE-Based Immunotoxins by Targeting Them to the Nucleus
por: Borowiec, Marta, et al.
Publicado: (2016)

Synergistic Anticancer Effects of the 9.2.27PE Immunotoxin and ABT-737 in Melanoma
por: Risberg, Karianne, et al.
Publicado: (2011)

MOC31PE immunotoxin – targeting peritoneal metastasis from epithelial ovarian cancer
por: Andersson, Yvonne, et al.
Publicado: (2017)

Anti-tumor activity of an immunotoxin (TGFα-PE38) delivered by attenuated Salmonella typhimurium
por: Lim, Daejin, et al.
Publicado: (2017)

Antitumor efficacy of D2C7-(scdsFv)-PE38KDEL, a novel immunotoxin targeting EGFRwt and EGFRvIII, by convection-enhanced delivery in orthotopic brain tumor mouse models
por: Bao, Xuhui, et al.
Publicado: (2013)

Phase I trial of EpCAM-targeting immunotoxin MOC31PE, alone and in combination with cyclosporin
por: Andersson, Y, et al.
Publicado: (2015)

Construction of an immunotoxin, HN3-mPE24, targeting glypican-3 for liver cancer therapy
por: Wang, Chunguang, et al.
Publicado: (2016)

Increased Local Inflammatory Response to MOC31PE Immunotoxin After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
por: Thorgersen, Ebbe Billmann, et al.
Publicado: (2021)

Targeting HER2-breast tumors with scFv-decorated bimodal nanoprobes
por: Alric, Christophe, et al.
Publicado: (2018)

Recombinant immunotoxins development for HER2-based targeted cancer therapies
por: Mahmoudi, Reza, et al.
Publicado: (2021)

The efficacy of NP11-4-derived immunotoxin scFv-artesunate in reducing hepatic fibrosis induced by Schistosoma japonicum in mice()
por: Li, Hong, et al.
Publicado: (2011)

Recombinant immunotoxin anti-c-Met/PE38KDEL inhibits proliferation and promotes apoptosis of gastric cancer cells
por: Wei, Xu, et al.
Publicado: (2011)

The MOC31PE immunotoxin reduces cell migration and induces gene expression and cell death in ovarian cancer cells
por: Wiiger, Merete Thune, et al.
Publicado: (2014)

Expanding the Therapeutic Window of EGFR-Targeted PE24 Immunotoxin for EGFR-Overexpressing Cancers by Tailoring the EGFR Binding Affinity
por: Jun, Sei-Yong, et al.
Publicado: (2022)

Synthesis of an Anti-CD7 Recombinant Immunotoxin Based on PE24 in CHO and E. coli Cell-Free Systems
por: Krebs, Simon K., et al.
Publicado: (2022)

Retargeting T Cells for HER2-Positive Tumor Killing by a Bispecific Fv-Fc Antibody
por: Wang, Lei, et al.
Publicado: (2013)

An anti-CD30 single-chain Fv selected by phage display and fused to Pseudomonas exotoxin A (Ki-4(scFv)-ETÁ) is a potent immunotoxin against a Hodgkin-derived cell line
por: Klimka, A, et al.
Publicado: (1999)

Design, Characterization, and Evaluation of scFvCD133/rGelonin: A CD133-Targeting Recombinant Immunotoxin for Use in Combination with Photochemical Internalization
por: Olsen, Cathrine Elisabeth, et al.
Publicado: (2019)

Clinical targeting recombinant immunotoxins for cancer therapy
por: Li, Meng, et al.
Publicado: (2017)

The Effect of the Targeted Recombinant Toxin DARPin-PE40 on the Dynamics of HER2-Positive Tumor Growth
por: Sokolova, E.A., et al.
Publicado: (2017)

PE38-based gene therapy of HER2-positive breast cancer stem cells via VHH-redirected polyamidoamine dendrimers
por: Moradian, Cobra, et al.
Publicado: (2021)

Immunotoxins: experimental design
por: Dall, P, et al.
Publicado: (2001)

Immunotoxins: The Role of the Toxin (†)
por: Antignani, Antonella, et al.
Publicado: (2013)

Countering immunotoxin immunogenicity
por: Flavell, David J
Publicado: (2016)

Biological Evaluation of (131)I- and CF750-Labeled Dmab(scFv)-Fc Antibodies for Xenograft Imaging of CD25-Positive Tumors
por: Fan, Qing, et al.
Publicado: (2014)

Interactions Between Pseudomonas Immunotoxins and the Plasma Membrane: Implications for CAT-8015 Immunotoxin Therapy
por: Bokori-Brown, Monika, et al.
Publicado: (2018)

Discovery of Hapten-Specific scFv from a Phage Display Library and Applications for HER2-Positive Tumor Imaging
por: Kim, Hye-Yeong, et al.
Publicado: (2014)

Treatment of solid tumors with immunotoxins
por: Messmer, Davorka, et al.
Publicado: (2005)

Bouganin, an Attractive Weapon for Immunotoxins
por: Bortolotti, Massimo, et al.
Publicado: (2018)

Immunotoxin Therapy for Lung Cancer
por: Xie, Li-Yi, et al.
Publicado: (2017)

FvMYB79 Positively Regulates Strawberry Fruit Softening via Transcriptional Activation of FvPME38
por: Cai, Jianfa, et al.
Publicado: (2021)

HER2-Specific Pseudomonas Exotoxin A PE25 Based Fusions: Influence of Targeting Domain on Target Binding, Toxicity, and In Vivo Biodistribution
por: Ding, Haozhong, et al.
Publicado: (2020)

High scFv-receptor affinity does not enhance the antitumor activity of HER2 retargeted measles virus
por: Suksanpaisan, Lukkana, et al.
Publicado: (2014)

High throughput cytotoxicity screening of anti-HER2 immunotoxins conjugated with antibody fragments from phage-displayed synthetic antibody libraries
por: Hou, Shin-Chen, et al.
Publicado: (2016)

Design and evaluation of a peptide-based immunotoxin for breast cancer therapeutics
por: Weigel, Kelsey J., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lre9u2jccsi2gifhqjl1950ilg